Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8447024 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7758400 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2792012 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8864030 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8864069 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7758405 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8192721 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7758415 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7759354 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28488945 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119143573-A | Synthesis method of 1, 2-diol and application of 1, 2-diol in cosmetics | 南京盛德创赢生物科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-104755510-A | Ziegler-Natta catalyst systems comprising a 1,2-phenylenedioate as internal donor and process for preparing the same | INDIAN OIL CORP LTD | 2015-07-01 | — | — | CN | claimed |
| CN-1047378-C | Method for synthesizing sex information hormone of bollworm | UNIV BEIJING POLYTECHNIC (CN) | 1999-12-15 | — | — | CN | claimed |
| US-4058541-A | Preparation of 2-alkanoyloxy-alkanoic | TEXACO INC. (US) | 1977-11-15 | — | — | US | claimed |
| US-4058540-A | FROM A NITROALKYL NITRATE OR NITRO ALCOHOL AND ALKANOIC ACID, CALCIUM OCIDE OR CARBOXYLATE CATALYST | TEXACO INC. (US) | 1977-11-15 | — | — | US | claimed |
| CN-109715721-A | Resin combination and resin-formed body | 富士施乐株式会社 | 2019-05-03 | — | — | CN | disclosed |
| CN-104755510-B | Ziegler natta catalyst system of internal donor and preparation method thereof is used as comprising 1,2 phenylene diester | 印度石油有限公司 | 2017-11-07 | — | — | CN | disclosed |
| CN-104755510-A | Ziegler-Natta catalyst systems comprising a 1,2-phenylenedioate as internal donor and process for preparing the same | INDIAN OIL CORP LTD | 2015-07-01 | — | — | CN | disclosed |
| CN-102197080-B | Thermoplastic cellulose ester composition and fibers made therefrom | TORAY INDUSTRIES | 2014-03-12 | — | — | CN | disclosed |
| CN-102197080-A | Thermoplastic cellulose ester composition and fibers made therefrom | TORAY INDUSTRIES | 2011-09-21 | — | — | CN | disclosed |
| CN-101903016-A | Bupropion hydrobromide and therapeutic uses | BIOVAIL LAB INT SRL | 2010-12-01 | — | — | CN | disclosed |
| US-20090076136-A1 | THERAPEUTIC AGENT | ENOKI TATSUJI | 2009-03-19 | — | — | US | disclosed |
| CN-1477173-A | Trigger response compositioin | 罗姆和哈斯公司 | 2004-02-25 | — | — | CN | disclosed |
| EP-0706509-B1 | SHORT CHAIN 2-HYDROXYCARBOXYLIC ACID-BASED DERIVATIVES OF CERAMIDES | DSM NV (NL) | 2000-01-05 | — | — | EP | disclosed |
| EP-0706509-A1 | SHORT CHAIN 2-HYDROXYCARBOXYLIC ACID-BASED DERIVATIVES OF CERAMIDES | GIST-BROCADES B.V. (NL) | 1996-04-17 | — | — | EP | disclosed |
| WO-1995029151-A1 | SHORT CHAIN 2-HYDROXYCARBOXYLIC ACID-BASED DERIVATIVES OF CERAMIDES | GIST-BROCADES B.V. (NL) | 1995-11-02 | — | — | WO | disclosed |
| CN-1098286-A | The osmotic bursting delivery devices that pH causes | PFIZER (US) | 1995-02-08 | — | — | CN | disclosed |
| EP-0339599-A2 | Process for producing acylaromatic compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-11-02 | — | — | EP | disclosed |
| US-4058541-A | Preparation of 2-alkanoyloxy-alkanoic | TEXACO INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-4058540-A | FROM A NITROALKYL NITRATE OR NITRO ALCOHOL AND ALKANOIC ACID, CALCIUM OCIDE OR CARBOXYLATE CATALYST | TEXACO INC. (US) | 1977-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076136-A1 | THERAPEUTIC AGENT | GPR119, IAPP, FABP4 | GPR84 564/4885FFAR1 124/4885MAPT 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.